Compassionate Use of Ubamatamab

ConditionsRenal Medullary Carcinoma (RMC)Epithelioid Sarcoma

Trial statusAvailable

Trial phaseNot listed

Trial typeExpanded Access

Biological sexNot listed

AgeNot listed

SponsorRegeneron Pharmaceuticals

About this trial

Provide Compassionate Use of Ubamatamab

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

ubamatamab

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Regeneron Pharmaceuticals

Lead sponsor

Source ClinicalTrials.gov